These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 21540856)

  • 21. Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.
    Zheng J; Liu Y; Qin G; Lam KT; Guan J; Xiang Z; Lewis DB; Lau YL; Tu W
    Eur J Immunol; 2011 Jan; 41(1):128-39. PubMed ID: 21182084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo maintenance of human regulatory T cells during CD25 blockade.
    Huss DJ; Mehta DS; Sharma A; You X; Riester KA; Sheridan JP; Amaravadi LS; Elkins JS; Fontenot JD
    J Immunol; 2015 Jan; 194(1):84-92. PubMed ID: 25416807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-17- and IFN-γ-secreting Foxp3+ T cells infiltrate the target tissue in experimental autoimmunity.
    Esposito M; Ruffini F; Bergami A; Garzetti L; Borsellino G; Battistini L; Martino G; Furlan R
    J Immunol; 2010 Dec; 185(12):7467-73. PubMed ID: 21098230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.
    Zhang X; Tao Y; Chopra M; Ahn M; Marcus KL; Choudhary N; Zhu H; Markovic-Plese S
    J Immunol; 2013 Dec; 191(12):5867-74. PubMed ID: 24198283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
    Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
    J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribavirin modulates the conversion of human CD4(+)  CD25(-) T cell to CD4(+)  CD25(+)  FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell.
    Kobayashi T; Nakatsuka K; Shimizu M; Tamura H; Shinya E; Atsukawa M; Harimoto H; Takahashi H; Sakamoto C
    Immunology; 2012 Nov; 137(3):259-70. PubMed ID: 22891772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.
    Takahashi R; Nishimoto S; Muto G; Sekiya T; Tamiya T; Kimura A; Morita R; Asakawa M; Chinen T; Yoshimura A
    J Exp Med; 2011 Sep; 208(10):2055-67. PubMed ID: 21893603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4
    Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
    Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
    Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
    Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
    Yurchenko E; Shio MT; Huang TC; Da Silva Martins M; Szyf M; Levings MK; Olivier M; Piccirillo CA
    PLoS One; 2012; 7(4):e35572. PubMed ID: 22545118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
    McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
    J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells.
    Kiapour N; Wu B; Wang Y; Seyedsadr M; Kapoor S; Zhang X; Elzoheiry M; Kasimoglu E; Wan Y; Markovic-Plese S
    J Immunol; 2022 Jul; 209(1):49-56. PubMed ID: 35750335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells.
    Hall BM; Tran GT; Robinson CM; Hodgkinson SJ
    Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
    Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4.
    Furlan R; Bergami A; Lang R; Brambilla E; Franciotta D; Martinelli V; Comi G; Panina P; Martino G
    J Neuroimmunol; 2000 Nov; 111(1-2):86-92. PubMed ID: 11063825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo expanded regulatory T cells CD4
    Lifshitz GV; Zhdanov DD; Lokhonina AV; Eliseeva DD; Lyssuck EY; Zavalishin IA; Bykovskaia SN
    Autoimmunity; 2016 Sep; 49(6):388-396. PubMed ID: 27424664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins.
    Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; Mol W; Weimar W; Baan CC
    Clin Exp Immunol; 2010 Aug; 161(2):364-77. PubMed ID: 20528886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmodium falciparum infection of the placenta impacts on the T helper type 1 (Th1)/Th2 balance of neonatal T cells through CD4(+)CD25(+) forkhead box P3(+) regulatory T cells and interleukin-10.
    Bisseye C; van der Sande M; Morgan WD; Holder AA; Pinder M; Ismaili J
    Clin Exp Immunol; 2009 Dec; 158(3):287-93. PubMed ID: 19758375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.